Tackling Inequalities in Dementia Risk
Health inequalities in the UK are damaging brain health, reducing life expectancy, and incurring significant costs – to individuals and society. These disparities are avoidable, unjust, and on the rise.
Tipping Point: The Future of Dementia
Our new report sets out a series of calls for party leaders ahead of the next general election. We believe these recommendations are vital to tackle the increasing pressure that dementia places on society, the NHS, and the economy.
Investing in dementia research boosts UK economy
If nothing changes, one in two of us will be directly affected by dementia, either by developing the condition ourselves, caring for someone, or both.
Addressing value and affordability
Following a workshop with stakeholders from the NHS, the National Institute for Health and Care Excellence (NICE), industry and academia, we examine the challenges and opportunities in assessing the value and affordability of new Alzheimer’s medicines.
Establishing a Clinical Trials Network
The creation of a ‘clinical trials network’ has huge potential to dramatically change the landscape for dementia research in the UK. Here, we set out our recommendations for how such a network could operate and deliver successful outcomes.
A joint statement on the voluntary scheme for branded medicines pricing and access (VPAS)
Patient charities set out a shared vision for the next VPAS scheme.
Improving dementia diagnosis: what could change in primary care?
The search for life-changing dementia treatments is beginning to yield tangible results. Now is the time for primary care to adapt to diagnosing people at the earliest stages of dementia, when treatments are most likely to be effective.
Five steps to delivering life-changing treatments for dementia
Alzheimer’s Research UK is calling on the new Prime Minister to follow five key steps to ensure the UK can be a world leader in dementia clinical research and help deliver life-changing treatments.
The Impact of Dementia on Women
Dementia devastates the lives of everyone it touches, but our analysis shows that women are bearing a disproportionate weight of the impact.
Dementia Attitudes Monitor: Wave 2 (2021)
Wave 2 builds on findings from Wave 1 (2018), shining a light on the UK’s attitudes towards dementia.
Are we ready to deliver disease modifying treatments?
Old Age Psychiatrists’ views on diagnosing and treating Alzheimer’s disease before dementia
The Right to Know: Accurate and Earlier Diagnosis of Dementia
Our vision of how to progressively reform and build dementia diagnostics capability in the UK.
Translating Science into breakthroughs: the future of late-stage dementia clinical trials in the UK
People with dementia are at risk of missing out on new treatments if the UK does not improve how it hosts clinical trials, according to a new report from Alzheimer’s Research UK.
Brain Health: A new way to think about dementia risk reduction
How we can use ‘brain health’ to transform the public’s attitude towards dementia risk reduction.
Delivering Dementia – Plan to find life-changing treatments
Alzheimer’s Research UK has called on government to invest in six priority research areas, which will help to deliver a life-changing treatment for dementia.
Detecting and diagnosing Alzheimer’s disease
Our report reveals public attitudes to early diagnosis of Alzheimer’s.
Dementia Attitudes Monitor: Wave 1 (2018)
A comprehensive review of public attitudes towards dementia and research, identifying key misperceptions and opportunities for shaping public attitudes towards the condition.
No time to lose: An action plan for dementia
The five actions government can take to improve the lives of people with dementia.
Brain Health consensus statement
Driving progress in dementia risk reduction by rallying health stakeholders around ‘brain health’.